Ascendance Biotechnology
200 Boston Avenue
Suite 1500
Medford
Massachusetts
02155
United States
Tel: 781-391-0205
Website: http://ascendancebio.com/
Email: info@ascendancebio.com
About Ascendance Biotechnology
Ascendance Biotechnology, Inc. (“Ascendance”) is a newly formed enterprise that combines the cutting edge micropatterning technologies, products and service offerings of Hepregen Corporation with the ESI BIO stem cell research products division of BioTime, Inc., offering unique cell-based assays and Solutions via ServiceTM for metabolite analysis and safety testing of new chemical entities, efficacy testing for new drug candidates, and laboratory products for basic research and product development.YEAR FOUNDED:
2015
LEADERSHIP:
Founders: Vincent R. Zurawski, Jr. and Jeffrey D. Janus
Founder and CEO: Vincent R. Zurawski, Jr.
PRODUCTS:
All Products
5 articles about Ascendance Biotechnology
-
The mysterious death of a biotech startup chief executive officer in late April projected the term biohacker into the forefront of the industry lexicon.
-
Just about every week has plenty of exciting news in the biopharmaceutical industry, and this week was no different. Here’s a brief look back at some of our top stories.
-
Biohacker Who Injected Himself with Untested Herpes Vaccine Found Dead in Sensory Deprivation Tank
5/2/2018
A biohacker who injected himself with an alleged experimental herpes vaccine before a crowded conference earlier this year was found dead in a Washington, D.C. sensory deprivation tank and the conspiracy theorists are running wild. -
BioTime Announces Cash Sale of Ascendance Biotechnology
3/27/2018
BioTime subsidiary, AgeX, to receive up to $3.5 million in cash
-
Ascendance Biotechnology Licenses The Right To Manufacture, Market And Sell Cytiva Cardiomyocytes
12/28/2016